TriSalus Life Sciences (TLSIW) Debt to Equity (2022 - 2025)
Historic Debt to Equity for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to -$1.23.
- TriSalus Life Sciences' Debt to Equity fell 1556.16% to -$1.23 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.23, marking a year-over-year decrease of 1556.16%. This contributed to the annual value of -$0.85 for FY2024, which is N/A changed from last year.
- TriSalus Life Sciences' Debt to Equity amounted to -$1.23 in Q3 2025, which was down 1556.16% from -$1.66 recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Debt to Equity registered a high of -$0.03 during Q1 2023, and its lowest value of -$1.66 during Q2 2025.
- Its 4-year average for Debt to Equity is -$0.75, with a median of -$0.88 in 2024.
- Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 164028.89% in 2024, then tumbled by 1556.16% in 2025.
- Over the past 4 years, TriSalus Life Sciences' Debt to Equity (Quarter) stood at -$0.09 in 2022, then skyrocketed by 43.54% to -$0.05 in 2023, then plummeted by 1583.86% to -$0.85 in 2024, then plummeted by 43.75% to -$1.23 in 2025.
- Its Debt to Equity stands at -$1.23 for Q3 2025, versus -$1.66 for Q2 2025 and -$0.92 for Q1 2025.